|
1
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fagioli F, Biasin E, Mereuta OM, Muraro M,
Luksch R, Ferrari S, Aglietta M and Madon E: Poor prognosis
osteosarcoma: new therapeutic approach. Bone Marrow Transplant. 41
(Suppl 2):S131–S134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin BC, Huang D, Yu CQ, Mou Y, Liu YH,
Zhang DW and Shi FJ: MicroRNA-184 modulates doxorubicin resistance
in osteosarcoma cells by targeting BCL2L1. Med Sci Monit.
22:1761–1765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bacci G, Balladelli A, Palmerini E,
Alberghini M, Pollastri P, Galletti S, Mercuri M and Picci P:
Neoadjuvant chemotherapy for osteosarcoma of the extremities in
preadolescent patients: the Rizzoli Institute experience. J Pediatr
Hematol Oncol. 30:908–912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li W, Xie P and Ruan WH: Overexpression of
lncRNA UCA1 promotes osteosarcoma progression and correlates with
poor prognosis. J Bone Oncol. 5:80–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bacci G, Ruggieri P, Bertoni F, Ferrari S,
Longhi A, Biagini R, Zavatta M, Versari M and Forni C: Local and
systemic control for osteosarcoma of the extremity treated with
neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli
experience. Oncol Rep. 7:1129–1133. 2000.PubMed/NCBI
|
|
7
|
Chen G, Fang T, Huang Z, Qi Y, Du S, Di T,
Lei Z, Zhang X and Yan W: MicroRNA-133a inhibits osteosarcoma cells
proliferation and invasion via targeting IGF-1R. Cell Physiol
Biochem. 38:598–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu P, Man Y, Wang Y and Bao Y: Mechanism
of BMP9 promotes growth of osteosarcoma mediated by the Notch
signaling pathway. Oncol Lett. 11:1367–1370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang L, Shrestha S, LaChaud G, Scott MA
and James AW: Review of microRNA in osteosarcoma and
chondrosarcoma. Med Oncol. 32:6132015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang J, Yu C, Chen M, Zhang H, Tian S and
Sun C: Reduction of miR-29c enhances pancreatic cancer cell
migration and stem cell-like phenotype. Oncotarget. 6:2767–2778.
2015.PubMed/NCBI
|
|
12
|
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H,
Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93, and miR-429
as potential biomarkers for detection of early stage non-small lung
cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Velletri T, Xie N, Wang Y, Huang Y, Yang
Q, Chen X, Chen Q, Shou P, Gan Y, Cao G, et al: P53 functional
abnormality in mesenchymal stem cells promotes osteosarcoma
development. Cell Death Dis. 7:e20152016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruan WD, Wang P, Feng S, Xue Y and Zhang
B: MicroRNA-497 inhibits cell proliferation, migration, and
invasion by targeting AMOT in human osteosarcoma cells. OncoTargets
Ther. 9:303–313. 2016. View Article : Google Scholar
|
|
16
|
Mirabello L, Koster R, Moriarity BS,
Spector LG, Meltzer PS, Gary J, Machiela MJ, Pankratz N, Panagiotou
OA, Largaespada D, et al: A genome-wide scan identifies variants in
NFIB associated with metastasis in patients with osteosarcoma.
Cancer Discov. 5:920–931. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi C, Li X, Xu W and Chen A: Relationship
between the expression of MTA-1 gene and the metastasis and
invasion in human osteosarcoma. J Huazhong Univ Sci Technolog Med
Sci. 25:445–447. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Park P, Zhang H, La Marca F,
Claeson A, Valdivia J and Lin CY: BMP-2 inhibits the tumorigenicity
of cancer stem cells in human osteosarcoma OS99-1 cell line. Cancer
Biol Ther. 11:457–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong Q, Fang J, Pang Y and Zheng J:
Prognostic value of the microRNA-29 family in patients with primary
osteosarcomas. Med Oncol. 31:372014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu L, van der Valk M, Cao J, Han CY, Juan
T, Bass MB, Deshpande C, Damore MA, Stanton R and Babij P:
Sclerostin expression is induced by BMPs in human Saos-2
osteosarcoma cells but not via direct effects on the sclerostin
gene promoter or ECR5 element. Bone. 49:1131–1140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gobbi G, Sangiorgi L, Lenzi L, Casadei R,
Canaider S, Strippoli P, Lucarelli E, Ghedini I, Donati D, Fabbri
N, et al: Seven BMPs and all their receptors are simultaneously
expressed in osteosarcoma cells. Int J Oncol. 20:143–147.
2002.PubMed/NCBI
|
|
22
|
Huo L, Liu K, Pei J, Yang Y, Ye Y, Liu Y,
Sun J, Han H, Xu W and Gao Y: Fluoride promotes viability and
differentiation of osteoblast-like Saos-2 cells via BMP/Smads
signaling pathway. Biol Trace Elem Res. 155:142–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu N, Tang LL, Sun Y, Cui RX, Wang HY,
Huang BJ, He QM, Jiang W and Ma J: MiR-29c suppresses invasion and
metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer
Lett. 329:181–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stamatopoulos B, Meuleman N, Haibe-Kains
B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P,
Bron D and Lagneaux L: microRNA-29c and microRNA-223
down-regulation has in vivo significance in chronic lymphocytic
leukemia and improves disease risk stratification. Blood.
113:5237–5245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lawrie CH, Ballabio E, Dyar OJ, Jones M,
Ventura R, Chi J, Tramonti D, Gooding S, Boultwood J, Wainscoat JS,
et al: MicroRNA expression in chronic lymphocytic leukaemia. Br J
Haematol. 147:398–402. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao S, Cheng C, Chen H, Li M, Liu K and
Wang G: IGF1 3′UTR functions as a ceRNA in promoting angiogenesis
by sponging miR-29 family in osteosarcoma. J Mol Histol.
47:135–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo W, Gorlick R, Ladanyi M, Meyers PA,
Huvos AG, Bertino JR and Healey JH: Expression of bone
morphogenetic proteins and receptors in sarcomas. Clin Orthop Relat
Res. 365:175–183. 1999. View Article : Google Scholar
|
|
28
|
Di Fiore R, Drago-Ferrante R, Pentimalli
F, Di Marzo D, Forte IM, D'Anneo A, Carlisi D, De Blasio A,
Giuliano M, Tesoriere G, et al: MicroRNA-29b-1 impairs in
vitro cell proliferation, self-renewal and chemoresistance of
human osteosarcoma 3AB-OS cancer stem cells. Int J Oncol.
45:2013–2023. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen G, Zhou T, Li Y, Yu Z and Sun L: p53
target miR-29c-3p suppresses colon cancer cell invasion and
migration through inhibition of PHLDB2. Biochem Biophys Res Commun.
487:90–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
